Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Anti-Inflammatory and Anti-Fibrotic Drugs on Post-acute COVID-19 Pulmonary Fibrosis

NCT05648734 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.

NCT NCT05648734
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05648734 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Anti-Inflammatory and Anti-Fibrotic Drugs on Post-acute COVID-19 Pulmonary Fibrosis
Lead sponsor
Mansoura University
Phase
Observational
Overall status
Completed
Start date
March 10, 2022
Completion date
September 15, 2022
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung fibrosis, post-covid-19 syndrome